inovio pharmaceuticals inc
J. Joseph Kim Ph.D.
Chief Executive Officer, President, Director and Member of Finance Committee, Inovio Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 3 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. J. Joseph Kim, Ph.D has been the Chief Executive Officer of Inovio Pharmaceuticals, Inc (alternate name: Inovio Biomedical Corp) since June 1, 2009 and has been its President since October 6, 2009. Dr. Kim co-founded ADViSYS Inc., a subsidiary of Viral Genomix in 1997 and serves as its Chief Executive Officer and President. He co-founded VGX Pharmaceuticals, LLC (Formerly Viral Genomix, Inc) in 2000 and served as its Chief Executive Officer and President from 2000 ...
Building 18Phone: 267-440-4200
Blue Bell, Pennsylvania 19422
Board Members Memberships*
Co-Founder, Chief Executive Officer, President and Director
Chief Executive Officer, President, Director and Member of Finance Committee
Massachusetts Institute of Technology
The University of Pennsylvania
University of Pennsylvania - The Wharton School
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Vijay B. Samant||Chief Executive Officer, President, Acting Chief Financial Officer and Director|
|Stanley C. Erck||Chief Executive Officer, President, Director and Member of Finance Committee|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|$533.3K||Compensation as of Fiscal Year 2013.|